Related Experiment Videos
Parenteral absorption of insulin from the lung in diabetic children
R B Elliott1, B W Edgar, C C Pilcher
1Department of Paediatrics, University of Auckland School of Medicine, New Zealand.
Australian Paediatric Journal
|October 1, 1987
Insights
Semi-synthetic human insulin delivered via a novel nebulizer to diabetic children showed blood glucose control comparable to traditional subcutaneous insulin injections.
Area of Science:
- Biomedical Engineering
- Pediatric Endocrinology
Background:
- Diabetes mellitus in children requires consistent blood glucose monitoring and management.
- Traditional insulin delivery methods include subcutaneous injections, which can be burdensome for pediatric patients.
Purpose of the Study:
- To evaluate the efficacy of a novel nebulizer for delivering semi-synthetic human insulin to the respiratory tract in children with diabetes.
- To compare the blood glucose control achieved with nebulized insulin to conventional subcutaneous insulin therapy.
Main Methods:
- Six children with diabetes received semi-synthetic human insulin via a novel nebulizer.
- Blood glucose levels were monitored and compared to a control day using standard subcutaneous insulin doses.
Main Results:
- Nebulized insulin delivery resulted in blood glucose control that was at least as effective as the control day with subcutaneous insulin.
- The novel nebulizer facilitated efficient delivery of insulin to the respiratory tract for glycemic management.
Conclusions:
- Nebulized semi-synthetic human insulin represents a viable alternative delivery method for pediatric diabetes management.
- This novel approach may offer improved patient compliance and a less invasive option compared to injections.
Abstract:
Semi-synthetic human insulin was delivered via a novel nebulizer to the respiratory tracts of six diabetic children. Blood glucose control obtained was at least as good as a control day when they received their usual dose of subcutaneous insulin.